Cns Segment
Dec 22, 2008 at 18:50
Photos »
/ 
Related News »
http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/orphan-diseases-therapeutics-in-cns-to-2017-novel-agents-such-as-amr101-and-acr16-to-provide-treatment-options-and-boost-the-huntington%E2%80%99s-disease-segment.html GBI ...
May 18, 2012 at 06:11 | Source: PR-USA.net
Westell segment revenue increased 12% due primarily to strong demand for products used in cellular backhaul initiatives offset by otherwise weaker demand for network interface and mounting products. CNS segment revenue increased 2%. In fiscal year 2011 ...
May 25, 2012 at 20:36 | Source: GuruFocus
A: If you look at the IPM data, the growth is basically coming from the diabetic segment, the central nervous system (CNS) segment and the cardiovascular segment. But, there is a low growth in anti-infective, nutritional products and in ...
May 22, 2012 at 09:26 | Source: MoneyControl.com
A 2009 study from Palmer's laboratory suggested that differences in Glo1 expression between mouse strains were due to copy number variants, where the segment of the genome ... we knew about inhibitory tone in the CNS. It turns out now that methylglyoxal ...
May 15, 2012 at 18:17 | Source: Science Daily
The EQT Production segment engages in the exploration ... drug products and a clinical pipeline of product candidates that address central nervous system (CNS) disorders, such as addiction, schizophrenia, and depression. It manufactures and commercializes ...
May 28, 2012 at 12:04 | Source: Seekingalpha.com
This CNS sale transaction closed on April 15 ... There are also copper and fiber connectivity products and remote site monitoring products. And an important fifth segment is composed of our cabinets, enclosures and mountings. I would also add to this ...
May 18, 2012 at 22:03 | Source: Seekingalpha.com
Small molecules constitute the largest segment of marketed drugs ... The three next largest shares of this market are held by drugs for the Central Nervous System (CNS), with 17.5%, and cardiovascular and respiratory disorders, with 11.9% and 8.2% respectively.
May 23, 2012 at 11:12 | Source: Business Wire
Antibodies Market Forecast to show Highest Growth Rate of all Classes of Immunomodulators Antibodies were the fastest growing segment in the global immunomodulators ... the treatment of Central Nervous System (CNS) disorders such as Alzheimer's disease ...
May 21, 2012 at 08:44 | Source: Transworld News